nanoComposix (Fortis Life Sciences)

San Diego, CA
Polymer Nanoparticle Metal Nanoparticle Silica Nanoparticle Iron Oxide Nanoparticle Nanomedicine CDMO
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: nanoComposix (Fortis Life Sciences)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
San Diego, CA
Modalities
Polymer Nanoparticle, Metal Nanoparticle, Silica Nanoparticle, Iron Oxide Nanoparticle, Nanomedicine CDMO
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About nanoComposix (Fortis Life Sciences)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesPolymer Nanoparticle, Metal Nanoparticle, Silica Nanoparticle, Iron Oxide Nanoparticle, Nanomedicine CDMO
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (5 modalities)

Frequently Asked Questions About nanoComposix (Fortis Life Sciences)

What is nanoComposix (Fortis Life Sciences)'s CDMO Signal Score?
nanoComposix (Fortis Life Sciences) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating nanoComposix (Fortis Life Sciences) for a manufacturing program?
Use the free AI matchmaker to compare nanoComposix (Fortis Life Sciences) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.